login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
OPTHEA LTD-SPON ADR (OPT) Stock News
USA
- NASDAQ:OPT -
US68386J2087
-
ADR
3.41
USD
+0.23 (+7.23%)
Last: 3/17/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
OPT Latest News, Press Relases and Analysis
All
Press Releases
2 months ago - By: Opthea Limited
Opthea Provides Corporate Update
7 months ago - By: Opthea Limited
Opthea Announces Decision to Discontinue Wet AMD Trials
7 months ago - By: Benzinga
- Mentions:
BRO
DNB
AZEK
AKYA
This Brown & Brown Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
7 months ago - By: Benzinga
- Mentions:
REGN
AMD
Opthea Phase 3 Trial Fails To Meet Primary Endpoint, Faces Financial Uncertainty
7 months ago - By: Opthea Limited
Opthea Announces COAST Phase 3 Trial Topline Results
8 months ago - By: Opthea Limited
Opthea Announces Phase 2b Wet AMD Publication
2 years ago - By: Opthea Limited
Opthea Appoints John Han, PharmD, as VP Medical Affairs
8 months ago - By: Opthea Limited
Opthea Reports Half Year Results and Business Updates
9 months ago - By: Opthea Limited
Opthea to Present at Oppenheimer Healthcare Conference
9 months ago - By: Opthea Limited
Opthea Wet AMD Data Featured at Macula Society Meeting
10 months ago - By: Opthea Limited
Opthea to Host Investor Days in New York and Australia
10 months ago - By: Opthea Limited
Opthea to Present at 43rd Annual J.P. Morgan Healthcare Conference
a year ago - By: Opthea Limited
Opthea’s Wet AMD Program to be Featured at FLORetina 2024
a year ago - By: Opthea Limited
Opthea to Participate in Citi 2024 Global Healthcare Conference
a year ago - By: Opthea Limited
Opthea Appoints Kathy Connell to Board of Directors
a year ago - By: Opthea Limited
Opthea Files Notice of Annual General Meeting
a year ago - By: Opthea Limited
Opthea Wet AMD Program to be Presented at Innovate Retina
a year ago - By: Opthea Limited
Opthea Appoints Chief Medical Officer and Chief Financial Officer as Company Prepares for Phase 3 Topline Data Readouts in 2025
a year ago - By: Opthea Limited
Opthea to Participate in the UBS Virtual Ophthalmology Day 2024
a year ago - By: Opthea Limited
Opthea Joins the S&P/ASX 300 Index
a year ago - By: Opthea Limited
Opthea Announces Completion of Drug Substance PPQ Campaign Validating Manufacturing Process of Sozinibercept
a year ago - By: Opthea Limited
Opthea to Have Significant Presence at the 24ᵗʰ EURETINA Congress and EURETINA Innovation Spotlight
a year ago - By: Opthea Limited
Opthea Announces Executive Leadership Changes and Senior Hires
a year ago - By: Opthea Limited
Opthea to Participate in H.C. Wainwright 26th Global Investment Conference and Cantor 2024 Global Healthcare Conference
a year ago - By: Opthea Limited
Opthea Reports Full-Year Financial Results and Business Updates
a year ago - By: Opthea Limited
Opthea to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference, August 15, 2024
a year ago - By: Opthea Limited
Opthea Welcomes International Retina Thought Leaders to Join Its Medical Advisory Board
a year ago - By: Opthea Limited
Opthea Announces Results of the A$55.9m (US$36.9m¹) Retail Entitlement Offer
a year ago - By: Opthea Limited
Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
a year ago - By: Opthea Limited
Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$171.5 million (US$113.2m¹)
a year ago - By: Opthea Limited
Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately A$227.3 million (US$150.0 million¹)
a year ago - By: Opthea Limited
Opthea To Present at Clinical Trials at the Summit Meeting
a year ago - By: Opthea Limited
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
a year ago - By: Opthea Limited
Opthea Announces Upcoming Presentations at the Retina World Congress 2024
1 years ago - By: Opthea Limited
Opthea to Present at the OIS Retina Innovation Summit at ARVO
2 years ago - By: Opthea Limited
Opthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare Conference
Please enable JavaScript to continue using this application.